Markets:

Overview

News

Currencies

International

Treasuries

Gilead Sciences (NQ:GILD)

135.29 +1.56 (+1.17%)

Streaming Delayed Price Updated: 10:56 AM EDT, May 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gilead Sciences

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

74 75 Next >

Gilead’s Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy and Safety Regardless of Prior Treatment History in New Data Presented at EASL 2025

May 07, 2025

From Gilead Sciences, Inc.

Via Business Wire

Market Monitor May 7 ( Hims & Hers Health, Upwork UP - Palantir, Monderna DOWN) ↗

May 07, 2025

Markets slide on vaccine regulation fears, trade uncertainty, and cautious earnings despite strong tech and consumer stock moves.

Via Chartmill

GILEAD SCIENCES INC (NASDAQ:GILD) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. ↗

May 06, 2025

When you look at GILEAD SCIENCES INC (NASDAQ:GILD), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.

Via Chartmill

1 Profitable Stock on Our Watchlist and 2 to Turn Down

May 05, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

3 Biotech Giants Gaining From U.S. Sales and Policy Shifts

May 02, 2025

The significant domestic revenue base of select US biotech companies offers stability potential for investors navigating global trade complexities.

Via MarketBeat

Topics Economy World Trade

Gilead Sciences Inc (NASDAQ:[GILD](https://www.chartmill.com/stock/quote/GILD)): A Dividend Stock Worth Considering ↗

May 01, 2025

Gilead Sciences Inc (NASDAQ:[GILD](https://www.chartmill.com/stock/quote/GILD)): A Dividend Stock Worth Considering

Via Chartmill

These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount ↗

April 30, 2025

Via The Motley Fool

Moderna (MRNA) Reports Earnings Tomorrow: What To Expect

April 30, 2025

Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results tomorrow before market hours. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence World Trade

Amgen (AMGN) Reports Earnings Tomorrow: What To Expect

April 30, 2025

Biotech company Amgen (NASDAQ:AMGN) will be reporting earnings tomorrow afternoon. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence Economy World Trade

Biogen Earnings: What To Look For From BIIB

April 30, 2025

Biotech company Biogen (NASDAQ:BIIB) will be announcing earnings results tomorrow before the bell. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence World Trade

What To Expect From BioMarin Pharmaceutical’s (BMRN) Q1 Earnings

April 30, 2025

Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) will be reporting earnings tomorrow after the bell. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence World Trade

Gilead Sciences to Present at Upcoming Investor Conferences

April 29, 2025

From Gilead Sciences, Inc.

Via Business Wire

Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis

April 29, 2025

From Gilead Sciences, Inc.

Via Business Wire

United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect

April 29, 2025

Biotechnology company United Therapeutics (NASDAQ:UTHR) will be reporting earnings tomorrow morning. Here’s what to look for.

Via StockStory

Topics Government World Trade

Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom ↗

April 28, 2025

Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...

Via Talk Markets

Topics ETFs Stocks / Equities

These S&P500 stocks are moving in today's session ↗

April 28, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Exploring the top movers within the S&P500 index during today's session. ↗

April 28, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Incyte (INCY) Q1 Earnings Report Preview: What To Look For

April 28, 2025

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be reporting results tomorrow morning. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence Government World Trade

Regeneron (REGN) Reports Earnings Tomorrow: What To Expect

April 28, 2025

Biotech company Regeneron (NASDAQ:REGN) will be reporting earnings tomorrow morning. Here’s what you need to know.

Via StockStory

Topics World Trade

Dividend Investor in Mid-50s Making $23,800 A Month Shares Portfolio, Says He Started with $3.50/hour — 'Just 35 Years of Investing' ↗

April 27, 2025

Via Benzinga

Why Gilead Sciences Stock Slipped Today ↗

April 25, 2025

Via The Motley Fool

How Is The Market Feeling About Gilead Sciences? ↗

April 25, 2025

Via Benzinga

Wall Street Rally Pauses, Tesla Heads For Strongest Week In 6 Months: What's Driving Markets Friday? ↗

April 25, 2025

Wall Street's three-day rally came to a pause on Friday, with major indices hovering near the flatline by midday in New York as caution returned amid mixed signals on U.S.-China trade relations.

Via Benzinga

Get insights into the top movers in the S&P500 index of Friday's pre-market session. ↗

April 25, 2025

Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session.

Via Chartmill

AbbVie Reports Upbeat Q1 Earnings, Raises 2025 Earnings Forecast: Retail’s Elated ↗

April 25, 2025

The company’s immunology drugs, Skyrizi and Rinvoq, marked significant revenue growth, offsetting a 50.6% decrease in net revenue from its arthritis drug, Humira.

Via Stocktwits

Topics World Trade

Gilead Sciences Q1 Earnings Surpass Analyst Expectations, But Revenue Falls Short Of Estimates: Retail’s Optimistic ↗

April 25, 2025

The company is eyeing FDA approval for its drug, lenacapavir, for HIV prevention by mid-June.

Via Stocktwits

Topics Government Stocks

Skechers Posts Weak Revenue, Joins Intel, Gilead Sciences And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

April 25, 2025

Via Benzinga

Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket ↗

April 25, 2025

Via Benzinga

Alphabet, Intel And 3 Stocks To Watch Heading Into Friday ↗

April 25, 2025

Via Benzinga

Which S&P500 stocks are moving after the closing bell on Thursday? ↗

April 24, 2025

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session.

Via Chartmill

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

74 75 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gilead Sciences (NQ:GILD)

All News about Gilead Sciences

Starting at $3.75/week.

Subscribe Today